Emodin promotes atherosclerotic plaque stability in fat-fed apolipoprotein E-deficient mice.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Tohoku journal of experimental medicine

• Publication date

  2008-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1620/TJEM.215.61PMID 18509236
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phytochemical dictionary. A handbook of bioactive compounds from plants.

  2009cited by this paper
• Emodin with PPARgamma ligand-binding activity promotes adipocyte differentiation and increases glucose uptake in 3T3-Ll cells.

  2007cited by this paper
• Emodin inhibits dietary induced atherosclerosis by antioxidation and regulation of the sphingomyelin pathway in rabbits

  2006cited by this paper
• Emodin inhibits vascular endothelial growth factor‐A‐induced angiogenesis by blocking receptor‐2 (KDR/Flk‐1) phosphorylation

  2006cited by this paper
• Alteration of subcellular redox equilibrium and the consequent oxidative modification of nuclear factor kappaB are critical for anticancer cytotoxicity by emodin, a reactive oxygen species-producing agent.

  2006cited by this paper
• Plaque Rupture After Short Periods of Fat Feeding in the Apolipoprotein E–Knockout Mouse: Model Characterization and Effects of Pravastatin Treatment

  2005influential reference
• Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway.

  2005cited by this paper
• Matrix Metalloproteinases in Cerebrovascular Diseases

  2005cited by this paper
• Changing the guard in long-term anticoagulation: clinical and economic implications.

  2004cited by this paper
• Identification and treatment of vulnerable plaque.

  2004cited by this paper
• Survival Signaling Generation of Reactive Oxygen Species and Inhibition of Emodin Enhances Arsenic Trioxide-Induced Apoptosis via

  2004cited by this paper
• From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

  2003influential reference
• Hepatic scavenger receptor class B, type I is stimulated by peroxisome proliferator-activated receptor gamma and hepatocyte nuclear factor 4alpha.

  2003cited by this paper
• Transmural coronary inflammation triggers simultaneous multivessel rupture of unstable plaques.

  2003cited by this paper
• Activation of Peroxisome Proliferator–Activated Receptor Gamma and Retinoid X Receptor Results in Net Depletion of Cellular Cholesteryl Esters in Macrophages Exposed to Oxidized Lipoproteins

  2003cited by this paper
• Hepatic scavenger receptor class B, type I is stimulated by peroxisome proliferator-activated receptor γ and hepatocyte nuclear factor 4α

  2003cited by this paper
• A New Paradigm for Plaque Stabilization

  2002cited by this paper
• Simvastatin Promotes Atherosclerotic Plaque Stability in ApoE-Deficient Mice Independently of Lipid Lowering

  2002cited by this paper
• Stabilization of atherosclerotic plaques: New mechanisms and clinical targets

  2002cited by this paper
• PPAR Activators as Antiinflammatory Mediators in Human T Lymphocytes: Implications for Atherosclerosis and Transplantation-Associated Arteriosclerosis

  2002cited by this paper
• PPARalpha activators inhibit tissue factor expression and activity in human monocytes.

  2001cited by this paper
• Unstable coronary plaque and its relation to coronary calcium.

  2001cited by this paper
• PPARα Activators Inhibit Tissue Factor Expression and Activity in Human Monocytes

  2001cited by this paper
• PPARα Agonists Inhibit Tissue Factor Expression in Human Monocytes and Macrophages

  2001cited by this paper
• Immune reponses in human mesangial cells regulated by emodin from Polygonum hypoleucum Ohwi.

  2001cited by this paper
• PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages.

  2001cited by this paper
• Antioxidant activity of anthraquinones and anthrone

  2000cited by this paper
• The Correlation of ATP-binding Cassette 1 mRNA Levels with Cholesterol Efflux from Various Cell Lines*

  2000cited by this paper
• Vulnerable plaque.

  1999cited by this paper
• PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells.

  1999cited by this paper
• Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-κB activation, IκB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells

  1998cited by this paper
• A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection

  1997cited by this paper
• Anti-inflammatory effects of emodin from ventilago leiocarpa.

  1996cited by this paper
• Effect of anthraquinone derivatives on lipid peroxidation in rat heart mitochondria: structure-activity relationship.

  1995cited by this paper
• High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules.

  1995cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

  1992cited by this paper
• Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

  1992cited by this paper
• Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties.

  1991cited by this paper
• Immune mechanisms in atherosclerosis.

  1989cited by this paper
• Immune mechanisms in atherosclerosis.

  1989cited by this paper

• Emodin Suppresses NLRP3/GSDMD-induced Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway in Atherosclerosis

  2024cites this paper
• Adiponectin and Adiponectin Receptors in Atherosclerosis.

  2024cites this paper
• Therapeutically important bioactive compounds of the genus Polygonum L. and their possible interventions in clinical medicine.

  2023cites this paper
• Mechanism of rhubarb in the treatment of hyperlipidemia: A recent review

  2023cites this paper
• Emodin attenuates high lipid-induced liver metastasis through the AKT and ERK pathways in vitro in breast cancer cells and in a mouse xenograft model

  2023cites this paper
• Trained immunity in monocyte/macrophage: Novel mechanism of phytochemicals in the treatment of atherosclerotic cardiovascular disease

  2023cites this paper
• Emodin accelerates diabetic wound healing by promoting anti-inflammatory macrophage polarization.

  2022cites this paper
• Effects of phytochemicals on macrophage cholesterol efflux capacity: Impact on atherosclerosis

  2021influential citation
• Combination of Activating Blood Circulation and Detoxifying Chinese Medicines Played an Anti-Inflammatory Role in Unstable Angina Patients after Percutaneous Coronary Intervention: A Multicenter, Open-Labeled, Randomized Controlled Trial

  2021cites this paper
• Emodin - A natural anthraquinone derivative with diverse pharmacological activities.

  2021cites this paper
• A Novel Molecular Pathway of Plaque Vulnerability Reveals a Cholesterol-Independent Effect of Statins and Supports Inflammation as a Therapeutic Target.

  2020cites this paper
• Targeting foam cell formation and macrophage polarization in atherosclerosis: The Therapeutic potential of rhubarb.

  2020cites this paper
• Emodin in atherosclerosis prevention: Pharmacological actions and therapeutic potential.

  2020cites this paper
• The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin.

  2020cites this paper
• Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products

  2019influential citation
• Medicinal Herbs Effective Against Atherosclerosis: Classification According to Mechanism of Action

  2019influential citation
• Tanshinone IIA Exerts Anti-Inflammatory and Immune-Regulating Effects on Vulnerable Atherosclerotic Plaque Partially via the TLR4/MyD88/NF-κB Signal Pathway

  2019cites this paper
• Medicinal Herbs Effective Against Atherosclerosis: Classification According to Mechanism of Action

  2019cites this paper
• Inhibitory effect of alpinetin on IL‐6 expression by promoting cytosine methylation in CpG islands in the IL‐6 promoter region

  2019cites this paper
• Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes.

  2018cites this paper
• Sonodynamic therapy: A potential treatment for atherosclerosis

  2018cites this paper
• Emodin ameliorates hepatic steatosis through endoplasmic reticulum–stress sterol regulatory element‐binding protein 1c pathway in liquid fructose‐feeding rats

  2016cites this paper
• Emodin suppresses LPS-induced inflammation in RAW264.7 cells through a PPARγ-dependent pathway.

  2016cites this paper
• Emodin and Its Role in Chronic Diseases.

  2016cites this paper
• Emodin regulates macrophage polarization: Application in breast cancer treatment

  2016influential citation
• Involvement of PPARγ in emodin-induced HK-2 cell apoptosis.

  2015cites this paper
• Chinese Herbal Compounds for the Prevention and Treatment of Atherosclerosis: Experimental Evidence and Mechanisms

  2015cites this paper
• Emodin Inhibits Homocysteine-Induced C-Reactive Protein Generation in Vascular Smooth Muscle Cells by Regulating PPARγ Expression and ROS-ERK1/2/p38 Signal Pathway

  2015cites this paper
• Most appropriate animal models to study the efficacy of statins: a systematic review

  2014cites this paper
• Emodin enhances cholesterol efflux by activating peroxisome proliferator‐activated receptor‐γ in oxidized low density lipoprotein‐loaded THP1 macrophages

  2014cites this paper
• Effect of emodin on the cariogenic properties of Streptococcus mutans and the development of caries in rats

  2014cites this paper
• Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides

  2014cites this paper
• Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs

  2014cites this paper
• Suxiaojiuxin Pill Enhances Atherosclerotic Plaque Stability by Modulating the MMPs/TIMPs Balance in ApoE-deficient Mice

  2014cites this paper
• Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.

  2013cites this paper
• Direct AT₂ receptor stimulation is athero-protective and stabilizes plaque in apolipoprotein E-deficient mice.

  2013cites this paper
• Atherosclerosis prevention by nutritional factors: a meta-analysis in small animal models.

  2013cites this paper
• Emodin, a Naturally Occurring Anthraquinone Derivative, Ameliorates Dyslipidemia by Activating AMP-Activated Protein Kinase in High-Fat-Diet-Fed Rats

  2012cites this paper
• Emodin Protects against High-Fat Diet-Induced Obesity via Regulation of AMP-Activated Protein Kinase Pathways in White Adipose Tissue

  2012cites this paper
• Herbal Remedies Supply a Novel Prospect for the Treatment of Atherosclerosis: A Review of Current Mechanism Studies

  2012cites this paper
• Sonodynamic effect of an anti-inflammatory agent--emodin on macrophages.

  2011cites this paper
• SONODYNAMIC EFFECT OFAN ANTI-INFLAMMATORYAGENT – EMODIN ON MACROPHAGES

  2011cites this paper
• Heparin inhibits the production of matrix metalloproteinase-2 and improves atherosclerosis in LDL receptor-deficient mice

  2010cites this paper
• Emodin ameliorates high-glucose induced mesangial p38 over-activation and hypocontractility via activation of PPARγ

  2009cites this paper